Breast cancer research in Asia: Adopt or adapt Western knowledge?

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 703-709

  Bhoo Pathy, Nirmala ^a,b,c   Yip, Cheng Har ^b   Hartman, Mikael ^d   Uiterwaal, Cuno S P M ^c   Devi, Beena C R ^e   Peeters, Petra H M ^c   Taib, Nur Aishah ^b   Van Gils, Carla H ^c   Verkooijen, Helena M ^d  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e SARAWAK GENERAL HOSPITAL   (Malaysia)

Author keywords

Asia; Asian; Breast cancer; Clinical research

Indexed keywords

ASIA; ATTITUDE TO HEALTH; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RESEARCH; CANCER RISK; CAUCASIAN; CULTURAL FACTOR; DRUG METABOLISM; HEALTH BELIEF; HEREDITY; HUMAN; INTERVENTION STUDY; LIFESTYLE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOCIAL STATUS;

EID: 84872683471     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.014     Document Type: Article

References (62)

1. Editorial Scaling up cancer diagnosis and treatment in developing countries: what can we learn from the HIV/AIDS epidemic? Ann Oncol 21 2010 680 682
2. S.S. Coughlin, and D.U. Ekwueme Breast cancer as a global health concern Cancer Epidemiol 33 2009 315 318
3. A. Seow, S.W. Duffy, M.A. McGee, J. Lee, and H.P. Lee Breast cancer in Singapore: trends in incidence 1968-1992 Int J Epidemiol 25 1996 40 45
4. Singapore Cancer Registry. Interim annual registry report. Trends in cancer incidence in Singapore 2006-2010. Available from: http://www.nrdo.gov.sg/ uploadedFiles/NRDO/Cancer-Trends-Report-06-10-final2.pdf.
5. K.S. Chia, M. Reilly, and C.S. Tan Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden Int J Cancer 113 2005 302 306
6. F. Bray, P. McCarron, and D.M. Parkin The changing global patterns of female breast cancer incidence and mortality Breast Cancer Res 6 2004 229 239 10.1186/bcr932
7. N.S. Wong, B.O. Anderson, and K.S. Khoo Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Lancet Oncol 10 2009 1077 1085
8. G. Agarwal, P.V. Pradeep, A. Aggarwal, C.H. Yip, and P.S. Cheung Spectrum of breast cancer in Asian women World J Surg 31 2007 1031 1104
9. A.H. Wu, M.C. Yu, C.C. Tseng, and M.C. Pike Epidemiology of soy exposures and breast cancer risk Br J Cancer 98 2008 9 14
10. W.P. Koh, D. Van Den Berg, A. Jin, R. Wang, J.M. Yuan, and M.C. Yu Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore Breast Cancer Res Treat 130 2011 1011 1019
11. K.P. Economopoulos, and T.N. Sergentanis Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis Breast Cancer Res Treat 120 2010 211 216
12. K.W. Singletary, and S.M. Gapstur Alcohol and breast cancer. Review of epidemiologic and experimental evidence and potential mechanisms JAMA 286 2001 2143 2151
13. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
14. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
15. K.E. Huang, L. Xu, N. Nasri, and U. Jaisamrarn The Asian Menopause Survey. Knowledge, perceptions, hormone treatment and sexual function Maturitas 65 2010 276 283
16. Y.Y. Teo, X. Sim, and R.T.H. Ong Singapore genome variation project: a haplotype map of three Southeast Asian populations Genome Res 19 2009 2154 2162
17. M. Hartman, C. Suo, Y.W. Lim, H. Miao, Y.Y. Teo, and K.S. Chia Ability to predict breast cancer in Asian women using a polygenic susceptibility model Breast Cancer Res Treat 127 2011 805 812
18. N. Bhoo Pathy, C.H. Yip, and N.A. Taib The impact of breast surgery on survival of women presenting with metastatic breast cancer Br J Surg 98 2011 1566 1572
19. G.M. Leung, T.H. Lam, T.Q. Thach, and A.J. Hedley Will screening mammography in the east do more harm than good? Am J Public Health 92 2002 1841 1846
20. E.H. Ng, F.C. Ng, and P.H. Tan Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project Cancer 82 1998 1521 1528
21. S.M. Tan, A.J. Evans, T.P. Lam, and K.L. Cheung How relevant is breast cancer screening in the Asia/Pacific region? Breast 16 2007 113 119
22. N. Bhoo Pathy, C.H. Yip, and N.A. Taib Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry Breast 20 2011 S75 S80
23. U.S. Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 151 2009 716 726
24. G. Maskarinec, L. Meng, and G. Ursin Ethnic differences in mammographic densities Int J Epidemiol 30 2001 959 965
25. J.B. Harford Breast cancer early detection in low and middle income countries: do what you can versus one size fits all Lancet Oncol 12 2011 306 312
26. B.C.R. Devi, T.S. Tang, and M. Corbex Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia Ann Oncol 18 2007 1172 1176
27. I. Mittra, M. Baum, H. Thornton, and J. Houghton Is clinical breast examination an acceptable alternative to mammographic screening? BMJ 321 2000 1071 1073
28. I. Mittra, G.A. Mishra, and S. Singh A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening Int J Cancer 126 2010 976 984
29. D.L. Sackett, and R.B. Haynes The architecture of diagnostic research BMJ 324 2002 539 541
30. S. Paik, S. Shak, and G. Tang A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826
31. M.J. van de Vijver, Y.D. He, and L.J. Van 't Veer A gene-expression Signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
32. S. Paik Is gene array testing to be considered routine now? Breast 20 2011 S87 S91
33. A. Kwong, O.W. Mang, and C.H. Wong Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001 Ann Surg Oncol 18 2011 3072 3078
34. P.M. Ravdin, L.A. Siminoff, and G.J. Davis Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 2001 980 991
35. S. Mook, M.K. Schmidt, and E.J. Rutgers Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study Lancet Oncol 10 2009 1070 1076
36. Early and Locally Advanced Breast Cancer: Diagnosis and Treatment [Internet]. NICE clinical guidelines, No. 80.Cardiff (UK): National Collaborating Centre for Cancer (UK); 2009. Appendix 1. Adjuvant! Online: review of evidence concerning its validity, and other considerations relating to its use in the NHS. [cited 2011 Sept 9]. Available from: http://www.ncbi.nlm.nih. gov/books/NBK11639/#appendixes.r12.
37. R.J. Epstein, T.W. Leung, J. Mak, and P.S. Cheung Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center Cancer Invest 24 2006 367 373
38. N Bhoo Pathy, C.H. Yip, and M. Hartman Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients Eur J Cancer 48 2012 982 989
39. M. Hartman, E.Y. Loy, and C.S. Ku Molecular epidemiology and its current clinical use in cancer management Lancet Oncol 11 2010 383 390
40. B.B.Y. Ma, E.P. Hui, and T.S.K. Mok Population-based differences in treatment outcome following anticancer drug therapies Lancet Oncol 11 2010 75 84
41. S. Lal, Z.W. Wong, and S.R. Jada Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients Pharmacogenomics 8 2007 567 575
42. L. Fan, B.C. Goh, and C.I. Wong Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity Pharmacogenet Genomics 18 2008 623 631
43. H.S. Han, I.M. Reis, and W. Zhao Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer Eur J Cancer 47 2011 2537 2545
44. Liou A, PAREXEL. Regulatory challenges in the Asia-Pacific region. Updated July, 2008. Available from: http://www.parexel.com/Insights/issue002/ Summer-Story.htm. [accessed 10 May, 2011].
45. Editorial Breast cancer in developing countries Lancet 374 2009 1567
46. P. Pisani, D.M. Parkin, and C. Ngelangel Outcome of screening by clinical examination of the breast in a trial in the Philippines Int J Cancer 118 2006 149 154
47. M. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 2001 533 543
48. American Cancer Society Global cancer facts & figures 2nd edition 2011 American Cancer Society Atlanta
49. CanTreat International. Access to cancer treatment in low and middle income countries. An essential part of global cancer control. A CanTreat Position Paper [2010 Aug]. Available from: http://axios-group.com/index.php/en/ highlights/new-cantreat-paper-released/.
50. B.O. Anderson, E. Cazap, and N.S. El Saghir Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010 Lancet Oncol 12 2011 387 398
51. P. Porter "Westernizing" women's risks? Breast cancer in lower-income countries N Eng J Med 358 2008 213 216
52. O.M. Jensen Planning a cancer registry O.M. Jensen, D.M. Parkin, R. Maclennan, Cancer registration: principles and methods 1991 IARC Lyon, France 22 28 Available from: http://www.iarc.fr/en/publications/pdfs-online/epi/sp95/ sp95-chap4.pdf
53. G. Ursin, A.H. Wu, and R.N. Hoover Breast cancer and oral contraceptive use in Asian-American women Am J Epidemiol 150 1999 561 567
54. R.G. Ziegler, R.N. Hoover, and M.C. Pike Migration patterns and breast cancer risk in Asian-American women J Natl Cancer Inst 85 1993 1819 1827
55. S.L. Gomez, T. Quach, and P.L. Horn-Ross Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status Am J Public Health 100 2010 S125 S131
56. P. Reynolds, S. Hurley, and D. Goldberg An excess of cancer risk among young California born Asian women Ethn Dis 21 2011 196 201
57. M.L. Tellj, E.T. Chang, and A.W. Kurian Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry Breast Cancer Res Treat 127 2011 471 478
58. C.M. Ko, G.R. Sadler, L. Ryujin, and A. Dong Filipina American women's breast cancer knowledge, attitudes, and screening behaviors BMC Public Health 3 2003 27
59. T. Hoare Breast screening and ethnic minorities Br J Cancer 74 1996 S38 S41
60. F.K. Koo, C. Kwok, K. White, N. D'Abrew, and J.K. Roydhouse Strategies for piloting a breast health promotion program in the Chinese-Australian population Prev Chronic Dis 9 2012 E03
61. S. Farooq, and M.P. Coleman Breast cancer survival in South Asian women in England and Wales J Epidemiol Community Health 59 2005 402 406
62. L.X. Clegg, F.P. Li, and B.F. Hankey Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology and end results) Program population-based study Arch Intern Med 162 2002 1985 1993